Royal Bank Of Canada Exact Sciences Corp Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in Exact Sciences Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 164,302 shares of EXAS stock, worth $9.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
164,302
Previous 79,987 105.41%
Holding current value
$9.44 Million
Previous $3.38 Million 231.07%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $3.58 Million - $5.97 Million
84,315 Added 105.41%
164,302 $11.2 Million
Q2 2024

Aug 14, 2024
SELL
$41.33 - $74.26 $5.74 Million - $10.3 Million
-138,793 Reduced 63.44%
79,987 $3.38 Million
Q1 2024

Nov 05, 2024
BUY
$56.27 - $73.77 $7.81 Million - $10.2 Million
138,793 Added 173.52%
218,780 $15.1 Million
Q1 2024

May 15, 2024
BUY
$56.27 - $73.77 $1.97 Million - $2.59 Million
35,075 Added 19.09%
218,780 $15.1 Million
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $791,049 - $1.01 Million
13,394 Added 7.86%
183,705 $13.6 Million
Q3 2023

Nov 14, 2023
BUY
$65.94 - $99.04 $454,326 - $682,385
6,890 Added 4.22%
170,311 $11.6 Million
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $3.39 Million - $5.14 Million
54,104 Added 49.49%
163,421 $15.3 Million
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $230,806 - $346,136
-4,891 Reduced 4.28%
109,317 $7.41 Million
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $621,112 - $1.09 Million
-20,465 Reduced 15.2%
114,208 $5.65 Million
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $2.77 Million - $4.28 Million
-86,642 Reduced 39.15%
134,673 $4.38 Million
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $3.29 Million - $7.03 Million
92,282 Added 71.52%
221,315 $8.72 Million
Q1 2022

May 16, 2022
BUY
$57.56 - $82.54 $178,954 - $256,616
3,109 Added 2.47%
129,033 $9.02 Million
Q4 2021

Feb 14, 2022
SELL
$72.5 - $100.68 $1.36 Million - $1.88 Million
-18,720 Reduced 12.94%
125,924 $9.8 Million
Q3 2021

Nov 15, 2021
SELL
$90.24 - $124.05 $49,632 - $68,227
-550 Reduced 0.38%
144,644 $13.8 Million
Q2 2021

Aug 16, 2021
BUY
$93.66 - $139.27 $13.6 Million - $20.2 Million
145,194 New
145,194 $18 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email